Si prevede che il mercato dei farmaci per immunoterapia crescerà da 186,32 miliardi di dollari nel 2021 a 476,04 miliardi di dollari entro il 2031; si prevede che crescerà a un CAGR del 14,4% dal 2022 al 2031.
L'aumento della domanda di anticorpi monoclonali è stato attribuito alla crescita del mercato dei farmaci per immunoterapia. Gli anticorpi monoclonali utilizzati in immunoterapia sono prodotti artificialmente da un clone cellulare e sono quindi costituiti da un unico tipo di immunoglobulina. Sono mirati verso antigeni specifici e si legano agli antigeni per formare un complesso. Gli anticorpi monoclonali possono essere utilizzati per trattare malattie come il cancro, l’artrite reumatoide, la sclerosi multipla, il lupus eritematoso sistemico e le malattie cardiovascolari. Secondo la Food and Drug Administration (FDA), fino al 2021 sono stati approvati più di 450 anticorpi monoclonali. Nel febbraio 2022, la FDA ha rilasciato un'autorizzazione all'uso di emergenza (EUA) per bebtelovimab, un nuovo anticorpo monoclonale efficace contro la variante omicron di SARS-CoV-2 . Il farmaco si è rivelato efficace nei pazienti adulti e pediatrici con sintomi da lievi a moderati o in coloro che sono ad alto rischio di progressione verso la forma grave di COVID-19.
DINAMICHE DEL MERCATO
La crescita del mercato dei farmaci immunoterapici è principalmente attribuita alla crescente domanda di malattie bersaglio, alla crescente domanda di biosimilari e anticorpi monoclonali e alla crescente adozione di categorie di farmaci immunoterapici rispetto ai metodi di trattamento tradizionali. Tuttavia, le sfide legate alla produzione di farmaci immunoterapici stanno ostacolando la crescita del mercato. Inoltre, la crescente domanda di trattamenti medicinali personalizzati sta guidando la crescita del mercato dei farmaci immunoterapici durante il periodo di previsione.
Approfondimenti strategici
AMBITO DI MERCATO
Il &ldquo ;Analisi del mercato globale dei farmaci immunoterapici fino al 2031” Il rapporto mira a fornire una panoramica del mercato dei farmaci immunoterapici con una segmentazione dettagliata del mercato in base al tipo, all’indicazione clinica e all’utente finale. Il rapporto fornisce statistiche chiave di mercato basate sulle prestazioni dei principali attori. Offre inoltre tendenze e opportunità chiave nel mercato.
SEGMENTAZIONE DEL MERCATO
Il mercato globale dei farmaci immunoterapici è segmentato in tipologie , indicazione clinica e utente finale. In base alla tipologia, il mercato è segmentato in adiuvanti vaccinali, attivatori delle cellule dendritiche e attivatori delle cellule dendritiche. fattori di crescita, stimolatori delle cellule T e amp; fattori di crescita, inibitori del checkpoint immunitario, anticorpi monoclonali, interleuchine e amp; interferoni e altri. Sulla base delle indicazioni, il mercato è segmentato in cancro, malattie infiammatorie, malattie autoimmuni, malattie infettive e altri. Il segmento degli utenti finali è ulteriormente segmentato in ospedali e strutture sanitarie. cliniche, centri chirurgici ambulatoriali e altri.
Il mercato globale dei farmaci immunoterapici è segmentato in cinque principali regioni: Nord America, Europa, Asia Pacifico, Medio Oriente & Africa e Sud & America Centrale. Il rapporto copre l'analisi e le previsioni di 18 paesi in tutto il mondo insieme alle tendenze e alle opportunità prevalenti nella regione.
Dal punto di vista regionale, il Nord America domina il mercato dei farmaci immunoterapici con una quota di mercato di circa il 40% nel 2021. La crescita del mercato nella regione è principalmente attribuita a la presenza di un gran numero di produttori di farmaci immunoterapici come F. Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co, Novartis International AG, Johnson & Johnson, Sanofi e GlaxoSmithKline Plc. La figura seguente mostra il trend di crescita dei ricavi nel mercato dei farmaci immunoterapici del Nord America:
< span style="font-family: verdana, geneva, sans-serif; font-size: 10pt;">Fonte: The Insight Partners Analysis
IMPATTO DELLA PANDEMIA DA COVID-19
L'epidemia di COVID-19 ha provocato un aumento della domanda di farmaci immunoterapici, che ha portato a un elevato volume di ordini tra i produttori di farmaci, con conseguente aumento del volume di produzione. L'aumento dei volumi di produzione ha aumentato il profitto dei prodotti di diversi produttori di componenti farmaceutici. Pertanto, l'approvvigionamento di componenti farmaceutici è aumentato durante la fase iniziale della diffusione della SARS-CoV-2, stimolando così la crescita del mercato globale dei farmaci immunoterapici.
La maggior parte della domanda è stata testimoniata dal target adiuvanti vaccinali. La Food and Drug Administration (FDA) statunitense ha concesso l’autorizzazione all’uso di emergenza per i vaccini Pfizer/BioNTech e Moderna contro il COVID-19. Questi farmaci sono stati raccomandati dagli operatori sanitari a persone di età pari o superiore a 16 anni, con una dose di 30 μg (0,3 m²) al costo di 19,50 dollari americani. Di conseguenza, l'approvvigionamento di farmaci è aumentato, il che rafforzerà il mercato dei farmaci immunoterapici durante il periodo di previsione.
Il rapporto include anche i profili dei principali farmaci immunoterapici società di mercato, insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie negli ultimi tre anni e sviluppi chiave negli ultimi cinque anni. Di seguito è riportato l'elenco di alcune aziende impegnate nel mercato dei farmaci immunoterapici:
- •Incyte Corporation•Juno Therapeutics•< span style="font-family: verdana, geneva, sans-serif; font-size: 10pt;">Celldex Therapeutics•Tesaro, Inc.•F. Hoffmann-La Roche Ltd •Amgen Inc.•Novartis AG•BioNTech SE•Sanofi•GlaxoSmithKline Plc•Pfizer Inc.< /span>•Merck & Co•Johnson & Johnson
Il team di ricerca e analisi dedicato del partner Insight è composto da professionisti esperti con competenza statistica avanzata e offre varie opzioni di personalizzazione nello studio esistente.
< img style="display: block; margine-sinistra: auto; margine-destra: auto;" src="https://www.theinsightpartners.com/assets/rdimages/immunotherapy-drugs-market-img2.png" alt="Ricerche di mercato" width="350" Height="350">
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Advanced Planning and Scheduling Software Market
- Redistribution Layer Material Market
- Dairy Flavors Market
- UV Curing System Market
- Sweet Potato Market
- Occupational Health Market
- Electronic Signature Software Market
- Wind Turbine Composites Market
- Virtual Production Market
- Vessel Monitoring System Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Immunotherapy Drugs Market is expected to grow at a CAGR of 15.5% between 2023-2031
The driving factors impacting the Immunotherapy Drugs Market are: Rising Cancer Prevalence, Advancements in Immunotherapy Research
The future trends of the Immunotherapy Drugs Market are: Personalized Immunotherapy, Combination Therapies
The leading players in the Immunotherapy Drugs Market are: Incyte Corporation, Juno Therapeutics, Celldex Therapeutics Tesaro, Inc., F. Hoffmann-La Roche Ltd , Amgen Inc., Novartis AG, BioNTech SE, Sanofi, GlaxoSmithKline Plc, Pfizer Inc., Merck & Co, Johnson & Johnson
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Eli Lilly and Company
2. Astrazeneca
3. Abbvie
4. Amgen inc
5. GlaxoSmithKline Plc
6. Novartis International AG
7. Merck and Co., Inc
8. F. Hoffmann-La Roche AG
9. Bristol-Myers Squibb
10. UbiVac
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.